Online Program Home
  My Program
Legend:
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

398 * Tue, 8/1/2017, 2:00 PM - 3:50 PM CC-346
Different Approaches to the Increase of a Sample Size When the Unblinded Interim Estimate of the Treatment Effect Looks Promising — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Mikhail Peter Salganik, Pfizer Worldwide Research & Development, Pfizer, Inc
Chair(s): Sandeep Menon, Pfizer, Inc
2:05 PM An Evaluation of Increasing Sample Size Based on Conditional Power Michael Gaffney, Pfizer Inc.
2:25 PM Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-Assessment Sam Hsiao, Cytel, Inc ; Lingyun Liu, Cytel, Inc ; Cyrus Mehta, Cytel Inc
2:45 PM Extensions of Adaptive Sample Size Re-Estimation Methods to the Negative Binomial Setting Mikhail Peter Salganik, Pfizer Worldwide Research & Development, Pfizer, Inc ; Sandeep Menon, Pfizer, Inc ; Abigail Sloan, Harvard T.H. Chan School of Public Health
3:05 PM Adapting the 5-Zone Adaptive Design Yi Liu, Takeda ; Mingxiu Hu, Takeda Pharmaceutical
3:25 PM Implementation of Promising Zone Methodology in a Ph 3 Trial in AML (VALOR) Jennifer Smith, Sunesis
3:45 PM Floor Discussion
 
 
Copyright © American Statistical Association